Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Case Study Previous | All Articles This Week | Next
This article originally posted 22 June, 2011 and appeared in  Type 2 DiabetesGLP-1 Series Issue 3GLP-1 Receptor Agonist TherapyBest of GLP-1CKD and Nephrology

A Caucasian Man with Newly Diagnosed Type 2 Diabetes and Renal Insufficiency, Part 1

Mr. Walker is a 59-year-old Caucasian who presents for evaluation of his type 2 diabetes, discovered 6 months ago by a random glucose measurement of 250 mg/dL using his wife's blood glucose meter....

Advertisement

Mr. Walker visited his physician a few days later at his wife's request and had an A1C measurement of 7.5%.

Despite his physician's recommendation at that time to go on medication to treat his diabetes, Mr. Walker insisted he felt fine and wanted to try diet and exercise to see if he could avoid medication. He stated that his wife, who also has type 2 diabetes, had the knowledge to help him with the changes.

In addition to his diabetes, Mr. Walker

  • has a 17-year history of hypertension and dyslipidemia, neither of which were well-controlled until 3 years ago
  • had a cardiac catheterization 3 years ago and was diagnosed with mild diffuse cardiovascular disease, but an intervention was not indicated at that time
  • has stable angina
  • was diagnosed with renal insufficiency 2 years ago

During the visit, Mr. Walker, who works as a construction supervisor, explained that he has had an increase in the amount of stress in his life during the past 6 months and that he has not been very successful at watching his diet. This has been putting a strain on his marriage and he states he now realizes he needs to get control of his diabetes in order to improve both his health and his marriage.

Case Details

Physical exam / review of systems

Laboratory values

Overweight male in no acute distress

A1C 8.3%

Height 71 inches

Fasting glucose average: 170 mg/dL

Weight 245 lbs

    (self-monitored the week prior to the visit)

BMI 34.2 kg/m2

2-hour postprandial plasma glucose: 270 mg/dL

Blood pressure 136/88 mmHg

    (self-monitored once after dinner)

1+ ankle edema

LDL 92 mg/dL

Foot exam normal

HDL 43 mg/dL

Most recent eye exam 10 months ago; no

Triglycerides 160 mg/dL

    retinopathy at that time

Creatinine 2.0 mg/dL

Current medications

BUN 49 mg/dL

Potassium 4.4 mEq/L

Simvastatin 40 mg daily

Estimated glomerular filtration rate (GFR) 37 mL/min

Ramipril 20 mg daily

Microalbumin 310 µg/mg creatinine

Hydrochlorothiazide 25 mg daily

 

Aspirin 81 mg daily

 
Question 1

Based on Mr. Walker’s initial presentation and laboratory values, what management recommendations, in addition to glycemic control, do you feel should be addressed at this visit?

1.    Add an agent to improve blood pressure management

2.    Optimize renal function

3.    Decrease cardiovascular disease risk

4.    Medical nutrition therapy

5.    All of the above

 
Best Answer: #5

All management areas (glycemic control, blood pressure, renal function, cardiovascular risk, and medical nutrition therapy) need to be addressed for this patient.

Question 1 Explanation: Improved glycemic control

Glycemic control, blood pressure, renal function, cardiovascular risk, and medical nutrition therapy all need to be addressed.  

Mr. Walker’s A1C of 8.3% is above goal:

  • American Diabetes Association (ADA) 2009 Clinical Practice Recommendations: <7.0%
  • American College of Endocrinology (ACE)/American Association of Clinical Endocrinologists (AACE): ≤6.5%
  • CADRE: The lowest A1C possible without unacceptable hypoglycemia, with action recommended at an A1C >7.0% (caution is recommended in children, the elderly, and higher risk populations)
Reducing and maintaining glycemic levels close to the non-diabetic range has been shown to reduce microvascular complications such as retinopathy, neuropathy, and nephropathy in people with type 2 diabetes, and may also reduce the risk of macrovascular disease.  

Mr. Walker is not currently on a medication to treat his diabetes, so one should be prescribed at this visit.

 

Question 1 Explanation: Improved blood pressure control 

Glycemic control, blood pressure, renal function, cardiovascular risk, and medical nutrition therapy all need to be addressed.  

Although Mr. Walker is currently on two medications, an ACE inhibitor and a thiazide diuretic, his blood pressure is above the level recommended. 

 

Recommended blood pressure for men with type 2 diabetes

 
Mr. Walker
ADA / AHA Recommendations
Blood pressure

136/88 mmHg

<130/80 mmHg

 
 

ADA = American Diabetes Association
AHA = American Heart Association

 


Guidelines for patients with a systolic blood pressure of 130 to 139 mmHg and a diastolic blood pressure of 80 to 89 mmHg are to initiate lifestyle modification with  

  • increased physical activity
  • weight loss
  • reduced sodium intake
  • an emphasis on increased consumption of fruits, vegetables, and low fat dairy products
  • moderation in alcohol consumption 

Because Mr. Walker has renal insufficiency, and tight blood pressure control may slow the progression of his kidney disease, lifestyle modification may not be enough and another medication should be added. 

 

Question 1 Explanation: Optimizing renal function

Glycemic control, blood pressure, renal function, cardiovascular risk, and medical nutrition therapy all need to be addressed.

It will be important to optimize Mr. Walker’s renal function, as it will slow the progression of his existing nephropathy. This can be achieved with excellent glycemic and blood pressure control. 

 

Question 1 Explanation: Decreasing cardiovascular risk

Glycemic control, blood pressure, renal function, cardiovascular risk, and medical nutrition therapy all need to be addressed.

Mr. Walker is currently taking simvastatin 40 mg daily for his dyslipidemia.

 

Recommended lipid levels for men with type 2 diabetes

 
Mr.Walker
ADA / AHA Recommendations
LDL

92 mg/dL

<100 mg/dL

HDL

43 mg/dL

>40 mg/dL

Triglycerides

160 mg/dL

<150 mg/dL

 

Because improving his glycemic control will likely improve his lipid parameters, it is acceptable to keep him on his current statin medication and reassess his need for additional medication at a follow-up visit.  

Optimizing Mr. Walker’s blood pressure will also reduce his cardiovascular disease risk.

 

Question 1 Explanation: Medical nutrition therapy 

Glycemic control, blood pressure, renal function, cardiovascular risk, and medical nutrition therapy all need to be addressed.

Mr. Walker needs multiple dietary changes due to his obesity, diabetes, hypertension, cardiovascular disease, and kidney disease. He and his wife need education from a registered dietitian to assist them in planning meals that meet all of his dietary needs. Mr. Walker should be encouraged to share meal planning responsibilities, which may reduce some of the stress in their marriage.

To be continued next week....
 
 
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 22 June, 2011 and appeared in  Type 2 DiabetesGLP-1 Series Issue 3GLP-1 Receptor Agonist TherapyBest of GLP-1CKD and Nephrology

Past five issues: Diabetes Clinical Mastery Series Issue 137 | Issue 677 | SGLT2 Special Edition Issue 2 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
Should a person newly diagnosed with prediabetes be treated with medication along with lifestyle changes?

Navigate Diabetes In Control
Search Articles On Diabetes In Control